Our approach

We’re problem-solving innovators for better care everywhere.

See Technology

We solve real problems

Our approach is to focus on making highly scalable devices that solve well-identified needs. 

Smiling older woman with gray hair pulled back, wearing a tan blazer and sitting comfortably in a chair, looking to the side in a warmly lit room.

Products with purpose

We want to see a world free from suffering caused by AMR infections, where everyone globally has equal access to excellent diagnostics.

Our 3 pillars of innovation

Start with a 
healthcare need

We look to solve problems that make a meaningful positive impact on people’s health, worldwide.

Design for excellence

We design with patients and clinicians at heart, breaking down problems to devise innovative solutions.

Develop for scale

Scalability brings down costs, and makes our diagnostics more accessible to all kinds of healthcare providers.

Our Journey

2021

Our company emerged from cutting-edge microbiology research performed at the world-renowned universities of Liverpool and Manchester.

2021/22

Point-of-Care became possible: our combined efforts with the University of Liverpool and Innovate UK propelled us from flow cytometry to microscopy.

2022/23

Prototyping and studies: we moved the benchtop test from the lab onto early prototype parts. Blinded technical studies with potential partners showed high levels of accuracy.

2024

Integrating the assay and gearing up to bringing Innotive Diagnostics to the market.

Ask us anything

Curious clinicians and interested investors - we’re looking forward to all your questions.

Contact us